River Glades Family Offices LLC Bristol Myers Squibb CO Transaction History

River Glades Family Offices LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $347,362 - $416,518	-5,650 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $8,901 - $10,011	-150 Reduced 2.59%	5,650 $357,000
Q4 2020 Jan 19, 2021	SELL	$57.74 - $65.43 $69,288 - $78,516	-1,200 Reduced 17.14%	5,800 $360,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $16,446 - $19,227	-300 Reduced 4.11%	7,000 $412,000
Q4 2019 Feb 18, 2020	SELL	$49.21 - $64.19 $49,210 - $64,190	-1,000 Reduced 12.05%	7,300 $469,000
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $49,082 - $54,274	1,100 Added 15.28%	8,300 $376,000
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $324,864 - $387,360	7,200 New	7,200 $344,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $302,312 - $392,026	-6,200 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $3,311 - $3,735	-60 Reduced 0.96%	6,200 $385,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $239,512 - $298,525	-4,740 Reduced 43.09%	6,260 $346,000
Q1 2018 May 10, 2018	BUY	$59.92 - $68.98 $126,730 - $145,892	2,115 Added 23.8%	11,000 $696,000
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $532,566 - $580,634	8,885	8,885 $544,000

2,404

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of River Glades Family Offices LLC, based on Form 13F filings with the SEC.

Stay updated on River Glades Family Offices LLC with notifications on news.